Medicines A-Z
Back to Solifenacin Tablet

Solifenacin Tablet Uses in Pakistan

Solifenacin Tablet (Vesicare) is a commonly prescribed medicine in Pakistan for overactive bladder and urinary urgency. This guide covers all approved uses, indications, and essential related information.

Compiled by the PakVita Editorial Team · AI-assisted drafting with editorial review · Sourced from DRAP, WHO, BNF · Last updated:

Uses

Quick Answer

Solifenacin Tablet (Vesicare) is used to treat overactive bladder (OAB), including urinary urgency, frequent urination, and urge urinary incontinence. It belongs to the Antimuscarinic class and works by relaxing the bladder muscle. Always take it as directed by your doctor.

Primary Uses at a Glance

Overactive Bladder (OAB)

Solifenacin blocks M3 muscarinic receptors in the detrusor muscle of the bladder, which stops involuntary contractions. It reduces urinary urgency, frequency (frequent urination), and urge incontinence. Full effect is reached in 4–6 weeks.

As prescribed by your doctor. Standard adult dose: 5mg once daily, may increase to 10mg.

Urge Urinary Incontinence

In urge incontinence, urine leaks suddenly before the patient can hold it. Solifenacin dampens the bladder's sudden urgency signals, which reduces incontinence episodes. This is a key symptom of OAB for which solifenacin is approved.

As prescribed by your doctor. Standard adult dose: 5mg once daily.

Detrusor Overactivity

Detrusor overactivity (DO) is a urodynamic diagnosis in which the bladder muscle contracts before voiding. Solifenacin controls this involuntary activity via M3 receptor blockade. Doctors diagnose this after urodynamic assessment.

As prescribed by your doctor after urodynamic assessment.

Other Uses

  • Urinary frequency reduction
  • Nocturia reduction

Solifenacin Tablet Uses (Fayde / Kis kaam aati hai)

Solifenacin Tablet contains Solifenacin Succinate and belongs to the Antimuscarinic / Anticholinergic group. Below are all the approved and common uses of Solifenacin Tablet (Vesicare) in Pakistan.

Primary Uses (Mukhya Istemal)

  • Overactive Bladder (OAB — peshaab baar baar aana, urinary urgency)
  • Urge urinary incontinence
  • Urinary frequency reduction
  • Detrusor overactivity

Who Should Take It (Kin logon ke liye)

  • Adults diagnosed with OAB by a doctor
  • Patients with urinary urgency or urge incontinence
  • Patients who have not benefited enough from pelvic floor exercises and bladder training
  • Patients with detrusor overactivity confirmed on urodynamics

When NOT to Use Solifenacin (Kab nahi leni chahiye)

  • Narrow-angle glaucoma — CONTRAINDICATED
  • Urinary retention or severe bladder outflow obstruction
  • Allergy to solifenacin or any ingredient
  • Severe myasthenia gravis or toxic megacolon

Summary

Solifenacin Tablet (Vesicare) is prescribed for overactive bladder (OAB), urge urinary incontinence, and detrusor overactivity. It is not for stress incontinence. Always take it after consulting a doctor.

The information in this guide is for educational purposes only.

Frequently Asked Questions

Solifenacin (Vesicare) kin conditions ke liye sabse zyada effective hai?

Solifenacin is most effective for overactive bladder (OAB), urinary urgency, urge urinary incontinence, and detrusor overactivity. Always take it only for the condition the doctor has prescribed it for.

Kya solifenacin doctor ke baghair le sakte hain?

No — solifenacin is an Rx (prescription) medicine. It must not be taken without a doctor's prescription under any circumstances. Self-medication can cause serious side effects.

Solifenacin kitne waqt mein kaam shuru karta hai?

Some patients notice a difference in 1–2 weeks, but the full therapeutic effect takes 4–6 weeks. Complete the course as directed by the doctor.

Kya solifenacin long-term le sakte hain?

Long-term use should only be done under doctor supervision. In elderly patients, long-term anticholinergic use carries a risk of cognitive effects — the doctor will conduct regular reviews.

Agar solifenacin kaam na kare to kya karein?

If results are not seen after the prescribed course, do not increase the dose on your own. See a doctor so the diagnosis can be reviewed and an alternative (such as mirabegron) considered.

Sources

  1. DRAP Registered Products Database — Drug Regulatory Authority of Pakistan
  2. WHO Model List of Essential Medicines, 23rd ed. (2023) — World Health Organization
  3. British National Formulary (BNF) — BMJ Group & Pharmaceutical Press

Medical disclaimer

This page is for educational use only and does not replace professional medical advice. Always confirm diagnosis, dose, and interactions with a qualified doctor or pharmacist before starting or changing any medicine.